ICD-10 Chapter I (A00–B99): Structure, Coding Boundaries, and Why Classification Is Not the Notifiable-Disease List

Direct answer: what A00–B99 is and is not

A00–B99 is the code range of Chapter I, “Certain infectious and parasitic diseases,” in the WHO International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). This reference uses the WHO 2019 version as its baseline, because the WHO classification portal currently lists 2019 as a browsable ICD-10 edition. Chinese hospitals work on top of this WHO skeleton with a national clinical extension and a payer (medical-insurance) code set; the six-character extended codes are a Chinese national elaboration, not part of the native WHO global structure.

The single most important boundary to state first: a classification chapter is not a statutory notifiable-disease list. China’s Law on the Prevention and Treatment of Infectious Diseases defines Class A/B/C notifiable diseases for legally mandated reporting; ICD-10 Chapter I is a statistical grouping for records, statistics, payment, and international comparison. Many diseases sit in both, but “falls in Chapter I” and “must be legally reported” cannot be inferred from each other.

• Is: a statistical classification block range used for the discharge abstract, statistics, payment, and research.
• Is not: a notifiable-disease list, a diagnostic standard, an efficacy endorsement, or a “report-if-in-Chapter-I” list.
• Baseline: WHO ICD-10 2019; China implementation uses the National Clinical Version 2.0 and Payer Version 2.0, subject to local-dictionary verification.

Why Chapter I is error-prone: four structural tensions

Clinical naming versus statistical classification. Terms such as “infectious gastroenteritis,” “sepsis,” or “lung infection” force the classifier to decide whether the organism is identified, whether tuberculosis is bacteriologically/histologically confirmed, and which body-system chapter owns a localized infection. Many localized infections (community-acquired pneumonia in Chapter X, urinary infection in Chapter XIV) do not enter Chapter I and instead take an optional B95–B97 agent code.

WHO base versus Chinese extension. The WHO four-character code is the internationally comparable minimum; China’s national clinical version adds six-character detail, and the payer version follows its own maintenance cycle. Treating one version’s detailed code as valid across all three systems causes interface rejection or mapping error.

Classification chapter versus statutory reporting — the highest-frequency mistake. Reading “A00–B99” as “the list of diseases requiring web-based direct reporting” produces both under-reporting (statutory diseases not reported per case definition and time limit) and over-reporting (non-statutory situations treated as reportable). Classification says what the disease is; statutory reporting says whether, when, and how it must be reported by law.

Evidence sufficiency versus code specificity. Confirmed (A15) versus unconfirmed (A16) respiratory tuberculosis are different categories; “confirmed HIV disease” versus “inconclusive serology/exposure” are different states. When documentation is insufficient, a more specific code must not substitute for clinical confirmation, and “suspected” cannot be uniformly coded as confirmed or uniformly excluded — the rule depends on inpatient, outpatient, or public-health context.

The skeleton: 21 blocks of Chapter I (WHO ICD-10 2019)

In WHO ICD-10 2019, Chapter I comprises 21 blocks organized by agent class and mode of transmission. Identifying the correct block is step one of the index-then-tabular method: locate the block, move to the three- and four-character categories, then reconcile with the Chinese clinical/payer detail and the local dictionary. Note that US ICD-10-CM differs from WHO here — most importantly, WHO uses B20–B24 for HIV disease, whereas ICD-10-CM collapses HIV to a single B20 category. Do not mix the two systems.

• A00–A09 Intestinal infectious diseases (cholera, typhoid/paratyphoid, salmonellosis, bacterial dysentery, amoebiasis, A09 gastroenteritis of infectious/unspecified origin).
• A15–A19 Tuberculosis (A15 bacteriologically/histologically confirmed respiratory TB; A16 unconfirmed; A17 nervous system; A18 other organs; A19 miliary).
• A20–A28 Certain zoonotic bacterial diseases (plague, tularaemia, anthrax, brucellosis, rat-bite fever, leptospirosis, etc.).
• A30–A49 Other bacterial diseases (leprosy, tetanus, diphtheria, whooping cough, scarlet fever, meningococcal infection, A40/A41 streptococcal and other sepsis).
• A50–A64 Infections with a predominantly sexual mode of transmission (syphilis, gonorrhoea, chlamydial and other STIs).
• A65–A69 Other spirochaetal diseases; A70–A74 other diseases caused by chlamydiae; A75–A79 rickettsioses.
• A80–A89 Viral and prion infections of the central nervous system (poliomyelitis, viral encephalitis, viral meningitis).
• A90–A99 Arthropod-borne viral fevers and viral haemorrhagic fevers (dengue, haemorrhagic fever with renal syndrome).
• B00–B09 Viral infections characterized by skin and mucous-membrane lesions (herpes simplex, varicella-zoster, measles).
• B15–B19 Viral hepatitis (B15 hepatitis A, B16 hepatitis B, B17 other acute, B18 chronic, B19 unspecified).
• B20–B24 HIV disease (WHO structure: categories by resulting condition — reconcile with Chinese clinical detail and payer codes).
• B25–B34 Other viral diseases; B35–B49 mycoses (candidiasis, aspergillosis); B50–B64 protozoal diseases (malaria and others).
• B65–B83 Helminthiases (schistosomiasis, filariasis); B85–B89 pediculosis, acariasis, and other infestations.
• B90–B94 Sequelae of infectious and parasitic diseases (e.g., B90 sequelae of TB — distinct from active disease).
• B95–B97 Bacterial and viral infectious agents (additional/supplementary codes for an agent in a disease classified elsewhere; never a stand-alone principal code).
• B99 Other infectious diseases (residual, NOS).

Within-chapter rules: agent codes, dagger/asterisk, sequelae, carriers

B95–B97 agent codes. When an infectious disease is classified to another chapter (a urinary infection in Chapter XIV, some pneumonias in Chapter X) and the organism must be named, use B95 (streptococcus/staphylococcus, etc.), B96 (other specified bacteria), or B97 (viruses) as an additional code. These identify the agent; they are never the principal diagnosis. Assigning a B95–B97 code as the principal code for active disease is a frequent Chapter I error.

Dagger (†) and asterisk (*) dual classification. ICD-10 marks the underlying cause with a dagger and an organ-specific manifestation with an asterisk (e.g., tuberculous meningitis carries an asterisk manifestation in the nervous system). The rule: an asterisk code is never used alone; it must accompany its dagger etiology code, and the dagger code is generally sequenced first. Ignoring this loses etiologic information or reverses sequencing.

Sequelae, carrier, contact, and active disease are distinct. B90–B94 are sequelae categories for residual problems of past infections, not current disease. Carrier state maps to Z22 (outside Chapter I); contact/exposure maps to Z20; active infection uses the relevant current-disease code in Chapter I. Mixing “old/sequela/carrier/contact” with “active” corrupts clinical, statistical, and public-health data at once.

• B95–B97: additional agent codes, never a stand-alone principal code.
• Asterisk codes: never used alone; pair with the dagger etiology code and mind the sequence.
• Sequelae → B90–B94; carrier → Z22; contact/exposure → Z20; active disease → Chapter I current code.
• HIV inpatient coding separates confirmed HIV disease, asymptomatic HIV status, and inconclusive serology.

Chapter priority and exclusions: infections that leave Chapter I

Chapter I carries explicit exclusion notes at its head. Infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium go to O98.- (Chapter XV); infections specific to the perinatal period go to P35–P39 (Chapter XVI); influenza and other acute respiratory infections go to J00–J22 (Chapter X); carrier or suspected-carrier status goes to Z22. These are chapter-priority rules: whenever the relevant population or setting appears, first check whether the case should leave Chapter I.

Practical meaning: a pregnant patient’s active hepatitis B may, in defined circumstances, require the O98 series rather than B16/B18 directly; a neonate’s congenital/perinatal infection favors the P chapter; an “upper respiratory infection / influenza-like” episode usually belongs in Chapter X. Whether chapter priority applies depends on the purpose of the encounter, the population, and current rules — confirmed against the tabular notes, not by a slogan that “all infections belong to Chapter I.”

• Infection in pregnancy/puerperium → O98.- (Chapter XV) takes priority.
• Perinatal-specific infection → P35–P39 (Chapter XVI) takes priority.
• Influenza and acute respiratory infection → J00–J22 (Chapter X), not Chapter I.
• Carrier / suspected carrier → Z22; contact/exposure → Z20 — outside Chapter I.

Five version layers: WHO, national standard, clinical version, payer version, local dictionary

WHO ICD-10 (2019 baseline here) supplies the internationally comparable three/four-character skeleton. China’s national standard GB/T 14396-2016, Classification and Codes of Diseases, is in force (its 2023-12-28 periodic review concluded “remains valid”) and defines chapters, blocks, three-character categories, four-character subcategories, and a six-character extended code. The National Clinical Version (business documents currently cite the National Clinical Version 2.0, 2022 consolidated) and the payer version on the medical-insurance coding platform each maintain further detail and usage rules.

Discipline: do not treat one version’s detailed code as universal; do not describe the Chinese six-character extension as a native WHO global structure; do not claim “clinical version equals payer version” or a strict one-to-one correspondence. What is actually live at a hospital interface is the local dictionary (with retired codes, replacement codes, and synonym mappings). Whether any final extended code is valid at a given hospital must be confirmed by local verification on the day of use. Because no hospital-specific dictionary was supplied for this page, six-character validity is marked “verify locally.”

• WHO ICD-10 2019: international statistical skeleton (3/4-character codes).
• GB/T 14396-2016: in-force national standard, 2023 review “remains valid,” with a six-character extension.
• National Clinical Version 2.0 (2022 consolidated): the version cited by current performance-monitoring documents.
• Payer Version 2.0: settlement codes; use results from the dynamic maintenance platform.
• Local dictionary: the effective interface layer; retirement/replacement/mapping require local verification.

One infection, six different identities across systems

Clinical diagnosis answers what the patient has and how to treat it; it is owned by the clinician and driven by clinical criteria, not by a code label. The discharge abstract (front sheet) expresses discharge diagnoses as classification codes for the inpatient summary, statistics, and quality management, with principal-diagnosis selection following front-sheet rules rather than a mechanical “most severe disease.” The payer settlement claim exists for settlement, payment, and oversight, uses payer-version codes, and is not a copy of the front sheet. DRG/DIP grouping consumes structured diagnosis and procedure data, but a group is neither a diagnostic standard nor a licence to reverse-engineer a diagnosis for a better group.

Public-health notification exists for surveillance, alerting, and control under the Infectious Diseases Law, the statutory list, case definitions, and reporting rules — mappable to ICD but not identical, the boundary this chapter most needs to stress. Mortality statistics use underlying-cause-of-death rules, and the inpatient principal diagnosis cannot stand in for the underlying cause. A research database treats a code as one phenotype element; a single code is not a real case. Understanding these six identities is the precondition for avoiding “code-correct but data-distorted” outcomes.

• Clinical diagnosis: clinician-owned; standard ≠ code label.
• Discharge abstract: principal diagnosis by front-sheet rules, not “most severe disease.”
• Payer claim: payer-version codes, not a front-sheet copy; reconcile with the interface dictionary.
• Public-health notification: by statutory list and case definition; mappable to ICD, not identical.
• Mortality statistics: underlying-cause rules, not the inpatient principal diagnosis.

Coding pathways: three teaching examples (de-identified)

Example 1 — infectious diarrhoea, organism unidentified. Adult with 3 days of acute watery diarrhoea, abnormal stool microscopy, negative stool culture, discharge diagnosis “acute infectious gastroenteritis.” Lead term “gastroenteritis → infectious,” tabular landing A09 (gastroenteritis and colitis of infectious and unspecified origin). Point: with no identified organism, do not invent an agent code or force a more specific category; recode only if the organism is later confirmed. Six-character detail: verify locally.

Example 2 — tuberculosis, confirmation status matters. Pulmonary TB, sputum smear- and culture-positive. Lead term “tuberculosis → lung,” tabular choice between A15 (bacteriologically/histologically confirmed) and A16 (unconfirmed); with microbiological confirmation, use the A15 subcategory. Point: confirmation status is determined by documentation, never defaulted; TB is also a statutory notifiable disease, so beyond coding it must be reported per case definition and time limit — a parallel action, not a substitute.

Example 3 — sepsis, a high-risk topic. E. coli bloodstream infection with secondary sepsis. Sepsis/septicaemia has categories in Chapter I (A40/A41 series), and the organism may be named with a B96 additional code; but principal-diagnosis selection, expression of organ dysfunction, and whether foreign guidance applies must return to the current Chinese code set and principal-diagnosis rules, anchored to the clinician’s final diagnosis and the record. Point: any diagnosis that affects CC/MCC, severity, or grouping demands a higher, not lower, evidence and audit standard; do not transplant US ICD-10-CM sepsis coding guidance.

• Organism unknown → unspecified category (e.g., A09); never invent an agent code.
• Tuberculosis → first decide “confirmed vs. unconfirmed,” selecting A15 or A16.
• Sepsis → name the organism with a B96 additional code; principal code and selection follow Chinese rules and the record, not US guidance.

Eight frequent errors and how to detect them

The list below pairs each error with why it is wrong and how it surfaces; every correction should be assigned to a specific role and leave an audit trail.

• B95–B97 agent code used as the principal diagnosis: violates its additional-code nature; surfaces as a principal that is a pure agent code with no disease code.
• Asterisk code used alone: etiology lost; surfaces as an asterisk code lacking its paired dagger code.
• Index consulted without the tabular list: inclusions/exclusions and chapter priority missed; surfaces as pregnancy/perinatal/respiratory infections mis-filed into Chapter I.
• Sequela and active disease conflated: B90–B94 used for current disease or vice versa; surfaces as a mismatch between clinical course and code tense.
• TB confirmation status misjudged: A16 coded where evidence supports A15 (or the reverse); surfaces as a code inconsistent with microbiology/pathology.
• Classification chapter treated as the notifiable list: statutory diseases under-reported or non-statutory events over-reported; surfaces on reconciliation against case definitions and the statutory list.
• One version’s detailed code used across all three systems: interface rejection or mapping error; surfaces as payer-interface errors and unreplaced retired codes.
• Suspected-diagnosis rule made absolute: uniformly coded as confirmed or uniformly excluded; surfaces where inpatient/outpatient/public-health contexts are not distinguished.

Critical boundary: classification, statutory reporting, and infection control are three systems

Legal basis. China’s Law on the Prevention and Treatment of Infectious Diseases was revised (second revision) on 30 April 2025 and took effect on 1 September 2025, defining Class A, B, and C notifiable diseases plus “sudden infectious diseases of unknown cause.” After this revision the statutory list totals 40 diseases (2 Class A, 27 Class B, 11 Class C). Class A: plague and cholera. Class B includes COVID-19, SARS, AIDS, viral hepatitis, pulmonary tuberculosis, rabies, dengue, mpox, syphilis, gonorrhoea, malaria, and schistosomiasis, among others. Class C includes influenza, mumps, hand-foot-and-mouth disease, and infectious diarrhoea other than cholera, bacterial/amoebic dysentery, and typhoid/paratyphoid. The list is adjusted dynamically: from 1 April 2026, chikungunya fever and severe fever with thrombocytopenia syndrome were placed under Class B management.

Statutory reporting time limits. Class A (and Class-B diseases managed as Class A, such as pulmonary anthrax and SARS) require web-based direct reporting within 2 hours; Class B and Class C require reporting within 24 hours. These are statutory rules executed by the first-attending clinician and reporting managers per case definition, running in parallel with — not in place of — medical record coding.

The three boundaries in one line: ICD Chapter I answers “what disease is this” (classification); the statutory list answers “whether, when, and how to report by law” (notification); hospital infection control answers “is this infection healthcare-associated and how is it monitored and managed” (IPC). A single infection may trigger all three or only one. Equating A00–B99 with the notifiable list, or equating IPC with statutory notifiable disease, is a structural error.

• Legal basis: Infectious Diseases Law, 2025 revision, in force 1 Sep 2025; Classes A/B/C plus unknown-cause.
• Dynamic change: from 1 Apr 2026, chikungunya fever and SFTS are managed as Class B.
• Time limits: Class A within 2 hours; Class B/C within 24 hours (statutory, per case definition).
• Three boundaries: ICD classification ≠ notifiable list ≠ hospital infection control.

The hospital loop: from anomaly to re-monitoring

Quality control for Chapter I data is a multi-role loop: clinicians own diagnosis and evidence documentation; coders own index-to-tabular work, additional codes, and sequencing; the health-information department owns completeness and consistency; the payer office owns the settlement claim and interfaces; the public-health section owns statutory reporting and case definitions; the quality-control office owns rules and review; the information department owns dictionary versions and interfaces; laboratory, imaging, and pathology supply microbiological and histological evidence.

Loop: anomaly detected → locate documentary evidence → clinical clarification (written, non-leading query) → diagnosis/procedure revision → coding review → synchronize front sheet and settlement claim → verify public-health reporting and payment interfaces → re-submit/correct → impact assessment → root-cause analysis (people/process/system/standard/incentive) → training and system-rule improvement → re-monitor. Throughout, preserve the version, editor, reason, and evidence location so the result is auditable.

Cross-system control table